Product Launch Planning

Launching a rare disease medicine poses unique challenges.

At Rare Medical Affairs we know that every product, rare disease, and person with a rare disease is unique.

One size does not fit all. One common element needed for success is a high-performing integrated cross-functional team that is empowered to ensure overall launch success.

At RMA, we use our own Rare Disease Medical Affairs Patient-Centric Framework to guide our approach to launch excellence and strategic planning. This framework enables us to focus on and prioritize the factors that impact launch success.

Understanding the patient journey in the context of the Healthcare Ecosystem.
Developing deep stakeholder relationships (patients, payers, HCPS) that will ensure engagement excellence on clinical data, product differentiation and value.
Ongoing evidence generation to support long term real world evidence generation (RWE).

Let’s talk about your upcoming launch planning and how RMA can work with your team to ensure launch success.